US HB7188 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on February 1 2024 - 25% progression
Action: 2024-02-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on February 1 2024 - 25% progression
Action: 2024-02-02 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.
Title
Shandra Eisenga Human Cell and Tissue Product Safety Act
Sponsors
| Rep. John Moolenaar [R-MI] | Rep. Debbie Dingell [D-MI] |
History
| Date | Chamber | Action |
|---|---|---|
| 2024-02-02 | House | Referred to the Subcommittee on Health. |
| 2024-02-01 | House | Referred to the House Committee on Energy and Commerce. |
| 2024-02-01 | House | Introduced in House |
Same As/Similar To
SB3733 (Same As) 2024-02-05 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/7188/all-info |
| Text | https://www.congress.gov/118/bills/hr7188/BILLS-118hr7188ih.pdf |
